|
½ÌÅ©ÅÊÅ©(ÁÖ) |
¿Ü±¹°èÁ¦¾àȸ»ç ÀÓ»ó±âȹ °æ·ÂÀÚ Ã¤¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
1³â¡è |
ä¿ë½Ã |
02.15 |
|
|
DOCS ICON Resourcing Solutions |
¿Ü±¹°è CRO-Study Authorization Associate (1¸í)
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
2³â¡è |
ä¿ë½Ã |
09.23 |
|
|
DOCS ICON Resourcing Solutions |
¿Ü±¹°è CRO- Jr. CRA (5¸í ä¿ë)
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
1³â¡è |
ä¿ë½Ã |
09.21 |
|
|
DOCS ICON Resourcing Solutions |
¿Ü±¹°èCRO-Project Manager
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
|
°æ·Â¹«°ü |
ä¿ë½Ã |
09.02 |
|
|
PharmaNet |
[Global CRO PharmaNet] °æ·Â CRA ±¸ÀÎ
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
03.30 |
|
|
(ÁÖ)ÀâÇ÷¯½º |
(ÁÖ5ÀÏ/¿Ü±¹°è±â¾÷)ÀÇ·á±â±â¹°·ù°ü¸® »ç¹«Á÷»ç¿ø¸ðÁý(°³²/
¼¿ï °³²±¸ | Çз¹«°ü |
¹«¿ª/ÇØ¿Ü¿µ¾÷/Åë¹ø¿ª |
°æ·Â¹«°ü |
ä¿ë½Ã |
07.07 |
|
|
µå¸²¼Ö·ç¼Ç |
30³â ÀÇ·á±â±â¾÷ ¿¬±¸¼Ò SMPS,FW,¾Æ³¯·Î±×HW °³¹ß °æ·ÂÁ÷ Ãæ
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
3³â¡è |
ä¿ë½Ã |
03.06 |
|
|
IMS Health Korea |
Account Manager ¹× Marketing Specialist(OncologyºÐ¾ß) ¸ð
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
3³â¡è |
ä¿ë½Ã |
09.12 |
|